Pancreatic Cancer and Diabetes Mellitus

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Pancreatic CancerSurgeryDiabetes Mellitus
Interventions
DIAGNOSTIC_TEST

All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data.

All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data.

Trial Locations (1)

200003

RECRUITING

Changzheng Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Changzheng Hospital

OTHER